ArticleFrontiers in immunology2022

Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.

Satoshi Takai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.